XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Revenues
Operating Expenses        
Research and development 2,203,748 2,644,244 9,946,268 7,324,730
General and administrative 3,407,088 1,869,636 7,389,269 5,690,953
Stock-based compensation – general and administrative 373,570 175,011 993,114 554,228
Total Operating Expenses 5,984,406 4,688,891 18,328,651 13,569,911
Operating Loss (5,984,406) (4,688,891) (18,328,651) (13,569,911)
Other Income (Expense)        
Other income 59,917   59,917 110,207
Interest income 103,413 13,018 186,224 44,463
Interest expense (2,932) (4,245) (10,839) (12,216)
Total Other Income, Net 160,398 8,773 235,302 142,454
Net Loss (5,824,008) (4,680,118) (18,093,349) (13,427,457)
Deemed dividend on warrant extension 1,450,876   1,450,876  
Net Loss Applicable to Common Stockholders $ (7,274,884) $ (4,680,118) $ (19,544,225) $ (13,427,457)
Net Loss Per Share Applicable to Common Stockholders - Basic and Diluted (in Dollars per share) $ (0.05) $ (0.11) $ (0.20) $ (0.38)
Weighted Average Common Shares Outstanding        
Basic and diluted (in Shares) 137,151,269 41,600,428 96,002,039 35,017,739